Luisa Coen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luisa Coen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Neusch
Experimental Medical Physics, Heinrich-Heine University Düsseldorf
1 shared publication - André Franken
Department of Obstetrics and Gynecology, Heinrich Heine University of Duesseldorf, 40225 Duesseldorf, Germany
1 shared publication - Cornelia Monzel
Experimental Medical Physics, Heinrich-Heine University, Universitätsstraße 1, 40225 Düsseldorf
1 shared publication - Daniel Alexander Kuckla
Experimental Medical Physics, Heinrich-Heine University, 40225 Düsseldorf, Germany
1 shared publication - Dieter Niederacher
Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany
1 shared publication - Eunike Sawitning Ayu Setyono
Center for Regenerative Therapies TU Dresden (CRTD), Center for Molecular and Cellular Bioengineering (CMCB), TU Dresden, 01307 Dresden, Germany
1 shared publication
Latest Publications
- Open Access
- 24 September 2024
- Published by MDPI AG in Colloids and Interfaces
- Vol. 8 (5) , 54
Mobile and Immobile Obstacles in Supported Lipid Bilayer Systems and Their Effect on Lipid Mobility
Diffusion and immobilization of molecules in biomembranes are essential for life. Understanding it is crucial for biomimetic approaches where well-defined substrates are created for live cell assays or biomaterial development. Here, we present biomimetic model systems consisting of a supported lipid bilayer and membrane coupled proteins to study the influence of lipid–lipid and lipid–protein interactions on membrane mobility. To characterize the diffusion of lipids or proteins, the continuous photobleaching technique is used. Either Neutravidin coupled to DOPE-cap-Biotin lipids or GFP coupled to DOGS-NTA lipids is studied at 0.005–0.5 mol% concentration of the linker lipid. Neutravidin creates mobile obstacles in the membrane, while GFP coupling results in immobile obstacles. By actin filament coupling to Neutravidin-lipid complexes, obstacles are crosslinked, resulting in lipid mobility reduction along with the appearance of a membrane texture. Theoretical considerations accurately describe lipid diffusion changes at high obstacle concentration as a function of obstacle size and viscous effects. The mobility of membrane lipids depends on the concentration of protein-binding lipids and on the concentration and charge of the coupled protein. Next to diffusion and friction coefficients, we determine the effective obstacle size as well as a charge-dependent effect that dominates the decrease in lipid mobility.
- 24 September 2024
- Published by MDPI AG in Colloids and Interfaces
- Vol. 8 (5) , 54
Open AccessMobile and Immobile Obstacles in Supported Lipid Bilayer Systems and Their Effect on Lipid Mobility
Diffusion and immobilization of molecules in biomembranes are essential for life. Understanding it is crucial for biomimetic approaches where well-defined substrates are created for live cell assays or biomaterial development. Here, we present biomimetic model systems consisting of a supported lipid bilayer and membrane coupled proteins to study the influence of lipid–lipid and lipid–protein interactions on membrane mobility. To characterize the diffusion of lipids or proteins, the continuous photobleaching technique is used. Either Neutravidin coupled to DOPE-cap-Biotin lipids or GFP coupled to DOGS-NTA lipids is studied at 0.005–0.5 mol% concentration of the linker lipid. Neutravidin creates mobile obstacles in the membrane, while GFP coupling results in immobile obstacles. By actin filament coupling to Neutravidin-lipid complexes, obstacles are crosslinked, resulting in lipid mobility reduction along with the appearance of a membrane texture. Theoretical considerations accurately describe lipid diffusion changes at high obstacle concentration as a function of obstacle size and viscous effects. The mobility of membrane lipids depends on the concentration of protein-binding lipids and on the concentration and charge of the coupled protein. Next to diffusion and friction coefficients, we determine the effective obstacle size as well as a charge-dependent effect that dominates the decrease in lipid mobility.
- Open Access
DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
Circulating tumor cells (CTCs) serve as crucial metastatic precursor cells, but their study in animal models has been hindered by their low numbers. To address this challenge, we present DanioCTC, an innovative xenograft workflow that overcomes the scarcity of patient-derived CTCs in animal models. By combining diagnostic leukapheresis (DLA), the Parsortix microfluidic system, flow cytometry, and the CellCelector setup, DanioCTC effectively enriches and isolates CTCs from metastatic breast cancer (MBC) patients for injection into zebrafish embryos. Validation experiments confirmed that MDA-MB-231 cells, transplanted following the standard protocol, localized frequently in the head and blood-forming regions of the zebrafish host. Notably, when MDA-MB-231 cells spiked (i.e., supplemented) into DLA aliquots were processed using DanioCTC, the cell dissemination patterns remained consistent. Successful xenografting of CTCs from a MBC patient revealed their primary localization in the head and trunk regions of zebrafish embryos. DanioCTC represents a major step forward in the endeavors to study the dissemination of individual and rare patient-derived CTCs, thereby enhancing our understanding of metastatic breast cancer biology and facilitating the development of targeted interventions in MBC. Summary statement: DanioCTC is a novel workflow to inject patient-derived CTCs into zebrafish, enabling studies of the capacity of these rare tumor cells to induce metastases.
Open AccessDanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
Circulating tumor cells (CTCs) serve as crucial metastatic precursor cells, but their study in animal models has been hindered by their low numbers. To address this challenge, we present DanioCTC, an innovative xenograft workflow that overcomes the scarcity of patient-derived CTCs in animal models. By combining diagnostic leukapheresis (DLA), the Parsortix microfluidic system, flow cytometry, and the CellCelector setup, DanioCTC effectively enriches and isolates CTCs from metastatic breast cancer (MBC) patients for injection into zebrafish embryos. Validation experiments confirmed that MDA-MB-231 cells, transplanted following the standard protocol, localized frequently in the head and blood-forming regions of the zebrafish host. Notably, when MDA-MB-231 cells spiked (i.e., supplemented) into DLA aliquots were processed using DanioCTC, the cell dissemination patterns remained consistent. Successful xenografting of CTCs from a MBC patient revealed their primary localization in the head and trunk regions of zebrafish embryos. DanioCTC represents a major step forward in the endeavors to study the dissemination of individual and rare patient-derived CTCs, thereby enhancing our understanding of metastatic breast cancer biology and facilitating the development of targeted interventions in MBC. Summary statement: DanioCTC is a novel workflow to inject patient-derived CTCs into zebrafish, enabling studies of the capacity of these rare tumor cells to induce metastases.